Press release
Inamed acquires patent for inhalation of Aspirin to treat virus infection
Gemuenden, Sep 16, 2005 – Germany based Inamed – Intelligent Aerosol Medicine today announced the acquisition of exclusive rights for inhaled aspirin to block the propagation of influenza viruses in the lung. The technology has been developed and patented by a team of German scientists. The licence agreement gives Inamed the possibility to market the patent worldwide and also to bring in Inamed’s technology for precise and targeted drug delivery to the lung.Dr. Gerhard Scheuch, founder and CEO of Inamed: “We are very happy about this acquisition, since we see the immense medical need for a better influenza therapy. We are looking forward to a further fruitful cooperation with this excellent research team.”
Talks to possible investors and marketing partners have already been started, while the concrete partnering strategy is still open. Scheuch: “We will decide in a short time frame whether to bring this project to a further level by ourselves or make this a licensing business. Several options are possible and the next steps depend on the feedback from our negotiations.”
Combining the drug with Inamed’s delivery technology can increase the market chances for Aspirin considerably. As shown in other projects, controlled inhalation helps to reduce dose variability and so leverages success probability within clinical projects.
About Aspirin inhalation
German researchers Stephan Ludwig (Muenster) Stephan Pleschka (Giessen) and Oliver Planz, (Tuebingen) focused their research on influenza virus induced cellular signaling and found that especially IKK and NF-kB are required for efficient influenza virus reproduction. Their work showed that aspirin can inhibit these important replication mechanisms, while being not toxic and not producing resistant virus variants.
About Inamed
Inamed GmbH - Intelligent Aerosol Medicine is a Germany-based drug delivery company, specializing in highly efficient aerosol technology and inhalation systems.
As a leading service provider for in-vitro and in-vivo inhalation studies, Inamed partners globally with leading pharmaceutical and biotechnology companies to apply their inhalation platforms to pharmaceuticals that require critical dosage control. Inamed is privately held and has facilities in Munich (R&D) and Gemuenden/Wohra (Headquarters and Logistics).
Contact
Axel Fischer Inamed GmbH-Intelligent Aerosol MedicineWohraer Str. 37
D – 35285 GemuendenGermany
Tel. +49 (0)6453 64818-0
Fax +49 (0)6453 64818-22
marketing@inamed.de ; www.inamed.de
Stephan Ludwig
Institute of Molecular Virology
Center for Molecular Biology of Inflammation (ZMBE)
Von-Esmarch-Str. 56
D-48149 Muenster
Germany
Tel. +49 251 835 7791
Fax. +49 251 835 7793
ludwigs@uni-muenster.de ; http://zmbe.uni-muenster.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inamed acquires patent for inhalation of Aspirin to treat virus infection here
News-ID: 188 • Views: …
More Releases for German
Find the best conditions for your German mortgage with Your German Mortgage
During times of the Coronavirus, we are here to help you with finding the right financing for your property.
Special times call for special measures, that's why it's now more important to find a trustworthy and experienced mortgage broker than ever.
We got you covered from finding your property of dreams all the way to financing it.
To ensure that, we have experts in almost every German major city,…
German Maritime Security 2018, German Government Statement!
Despite all international and national efforts, piracy remains a serious peril for the international shipping industry.
Especially in Asia (i.e. Chittagong/Bangladesh or on the Strait of Malacca), but also in South America (e.g. Bay of Santos/Brazil or in the port of Callao/Peru) robbery or piracy there has recurred in the recent past. At the West African coast the number of incidents had raised even by 50% with 66 incidents this…
More German Investments Mean More German Translations
Why Language Continues to be an Obstacle for Investing in Germany
Germany is one of the prime markets for foreign investments, with an estimated 4% of global direct investment making its way into the country. In fact, the world’s second richest man, Warren Buffett, who is only beaten to the top spot on the financial leaderboard by Microsoft Founder Bill Gates, believes Germany to be a ‘great market’, and confirms the…
German Design Award 2015
German Design Council Awards a Special Mention to the LR 1000 Laboratory Reactor and Nominates the Tube Mill
Staufen, Germany, February 23, 2015 —
For the second time, a device produced by IKA® Werke has received the "Special mention for exceptional design quality" award from the German Design Council.
The company was presented with the award in the "Excellent Product Design — Industry" category as part of the German Design Award 2015…
German Local Trade Tax
All the companies in Germany are liable to pay not only corporate income tax, whose rate is nowadays about 15% of the annual profit of the company, but also trade tax (Gewerbesteuer), which is a tax of German characteristics.
Why would we say that trade tax is of German characteristics? Because it is different from the corporate income tax, which is charged by the German Federal Government and it is difficult…
ISPA – German Masters 2008
Magdeburg – Over the long weekend of the 4. Mai more than 1.000 Skat players filled the Mittelland hall in Barleben. The tournaments of the 30. German Mastery and the 27. open International German Single Mastership were held by the International Skat Players Association, ISPA Germany. Patrons of the Games were the 1st Barleber Skat sports club e.V. and the Skat club \"Burger Ihleskater\", whose good organization together with the…
